Skip to main content
. 2021 Oct 4;11(10):164. doi: 10.1038/s41408-021-00558-5

Fig. 4. Posttransplant outcome of patients depending on pre-transplant MRD status assessed by flow cytometry (FC).

Fig. 4

Among patients with CR/CRi (n = 85) after CPX-351-based induction data on MRD estimated by FC were available for 36 patients (42%) representing MRD negativity in 64% of the patients (n = 23). The figure represents outcome in terms of overall and relapse-free survival for patients with pre-transplant CRMRD− (n = 23, green line) and CRMRD+ (n = 13, orange line).